By Marc Hurlbert | CEO
The Melanoma Research Alliance (MRA) and our collaborators at the Veterans Administration (VA) Hospitals in Boston and Providence, and at Massachusetts General Hospital (MGH), have finalized our veteran and civilian cohorts. Among civilians, we found that for acral melanoma, ‘normal weight/normal BMI’ was associated with reduced risk. Importantly, among Veterans, we have found an association among Agent Orange exposure increased risk for acral melanoma. This work has been submitted for peer-review at the prestigious journal, JAMA Dermatology. We await feedback from peer review. Concurrently, the team found that heightened immune system function is associated with protection from or lower risk of uveal melanoma. This work has also been submitted to a peer-reviewed journal. The final remaining work – looking at any risk associated with inherited genes – has taken longer than anticipated; the Department of Defense has granted us a second 1-year no cost extension to complete the work by September 2026.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser